ArticleEuropean journal of public health2026
A cross-sectional study unveiling the global impact and future projections through 2060 of osteoarthritis.
Article in European journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Multimodality imaging considerations for genicular artery embolization in knee osteoarthritis.World journal of radiology · 2026Review
- A prospective cohort study develops and validates a machine learning model for predicting ecchymosis after total knee arthroplasty.Scientific reports · 2026Article
- Metabolic pathways linking air pollution to osteoarthritis: Insights from a prospective cohort.PloS one · 2026Article
- Global burden of liver cirrhosis: trends from 1990-2021 and projections to 2060.Journal of health, population, and nutrition · 2025Article
- Social determinants of health and all-cause or cardiovascular mortality on osteoarthritis adults in the USA: a national cohort study.Frontiers in public health · 2025Article
- Multi-targeted inhibition of NF-κB signaling underlies the anti-osteoarthritic effects of BGJXF and its key component dehydrocorydaline.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Osteoarthritis is a leading degenerative disease worldwide that significantly impairs physical function and quality of life. With an ageing population, the epidemiological burden of osteoarthritis is expected to intensify, making systematic analysis and trend prediction essential for refining treatment and prevention strategies. Data from the 2021 Global Burden of Disease database was employed to analyse trends in the incidence, prevalence, and disability-adjusted life years of osteoarthritis from 1990 to 2021. This research spans global, regional, and national perspectives, aiming to guide future health interventions. By 2021, the number of patients affected by osteoarthritis had reached 607 million, with predictions estimating a rise to 765 million by 2060. There is a positive correlation between Social Development Index and osteoarthritis burden, illustrating that higher incidence and prevalence rates are associated with greater economic development. East Asia currently leads with the highest count of osteoarthritis cases, whereas Oceania has the fewest. Osteoarthritis incidence is climbing across all adult age groups, with women consistently exhibiting higher rates than men at every age. High body mass Index stands as the most significant risk factor for the condition. The total number of osteoarthritis cases is expected to keep rising, underscoring the ongoing challenge in managing this pervasive disease. Osteoarthritis persists as a substantial global health challenge, exhibiting a continuous upward trend from 1990 to 2021. This study provides critical insights for public health policy-making and resource allocation, supporting future interventions and disease control efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.